Search results
Results from the WOW.Com Content Network
Clofazimine also showed a dosage-dependent inhibition of neutrophil motility, lymphocyte transformation, [19] mitogen-induced PBMC proliferation [20] and complement-mediated solubilization of pre-formed immune complexes in vitro. [21] A mechanistic studying of clofazimine in human T cells revealed that this drug is a Kv1.3 channel blocker. [22]
The K v 1.3 blocker clofazimine has been reported to be effective in the treatment of chronic graft-versus-host disease, [60] cutaneous lupus, [61] [62] and pustular psoriasis [63] [64] in humans. Furthermore, clofazimine in combination with the antibiotics clarithromycin and rifabutin induced remission for about 2 years in patients with Crohn ...
This is a major advantage of clofazimine over other antileprosy drugs. Ulcerative lesions caused by Mycobacterium ulcerans respond well to clofazimine. It also has some activity against M. tuberculosis and can be used as last resort therapy for the treatment of MDR tuberculosis. The most disturbing adverse reaction to clofazimine is a red-brown ...
Researchers have recently discovered that one night of complete sleep deprivation is extremely detrimental to your overall health. Health 101: Why pulling an all-nighter is worse for your body ...
Clofazimine's mechanisms are not fully understood regarding Mycobacterium leprae, but the drug's binding appear to occur at base sequences with guanine, which may explain why clofazimine has a preference for G+C rich genomes of mycobacteria over human DNA. The binding of clofazimine to mycobacterial DNA can has been proven as weakly ...
They are not metabolized by the body but are excreted by the kidneys. Dwell time in the body varies greatly by species. Rodents have half-lives of days, while in humans they remain for years. Many animals show sex differences in the ability to rid the body of PFAAs, but without a clear pattern. Gender differences of half lives vary by animal ...
Excessive red wine consumption could promote inflammation in the body and contribute to health issues like liver disease, cardiovascular disease and immune dysfunction, says Routhenstein.
Every regimen should contain either azithromycin or clarithromycin; many experts prefer ethambutol as a second drug. Many clinicians have added one or more of the following as second, third, or fourth agents: clofazimine, rifabutin, rifampin, ciprofloxacin, and in some situations amikacin.